# Dose Finding Trial of R21/Matrix-M in School Children

> **NCT07074665** · PHASE2 · RECRUITING · sponsor: **University of Oxford** · enrollment: 40 (estimated)

## Conditions studied

- Malaria (Plasmodium Falciparum)

## Interventions

- **BIOLOGICAL:** 5µg R21/50µg Matrix-M
- **BIOLOGICAL:** 10µg R21/50µg Matrix-M

## Key facts

- **NCT ID:** NCT07074665
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-18
- **Primary completion:** 2026-04
- **Final completion:** 2027-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07074665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07074665, "Dose Finding Trial of R21/Matrix-M in School Children". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07074665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*